Skip to main content
. Author manuscript; available in PMC: 2014 Dec 15.
Published in final edited form as: Cancer. 2014 Jul 9;120(22):3575–3583. doi: 10.1002/cncr.28892

TABLE 3.

Self-Reported Side Effects

Gabapentin (n = 207) Placebo (n = 206) Pa
Drowsiness .51
 Mean (SD) 1.4 (2.5) 1.6 (2.6)
Concentration .48
 Mean (SD) 1.0 (2.6) 1.1 (2.5)
Diarrhea .46
 Mean (SD) 0.5 (2.0) 0.4 (2.0)
Skin irritation .30
 Mean (SD) 0.1 (1.7) 0.1 (1.6)
Swelling of hands/feet .78
 Mean (SD) 0. 1 (1.6) 0.0 (1.2)
Dry mouth .20
 Mean (SD) 1.6 (2.4) 1.2 (2.4)
Dizziness .25
 Mean (SD) 1.3 (2.4) 0.9 (2.1)
Constipation .96
 Mean (SD) 2.0 (3.0) 2.0 (3.0)
Tiredness .11
 Mean (SD) 2.3 (3.0) 2.8 (3.0)
Headache .42
 Mean (SD) 1.3 (2.6) 1.3 (2.5)
Indigestion/heartburn .71
 Mean (SD) 2.0 (3.0) 1.9 (2.9)
Anxiety/nervousness .19
 Mean (SD) −0.8 (2.9) −0.4 (2.9)
Weight gain .45
 Mean (SD) 0.3 (1.9) 0.1 (1.4)
Appetite loss .04
 Mean (SD) 1.3 (2.7) 1.9 (3.3)
Loss coordination
 Mean (SD) 0.4 (1.5) 0.4 (1.6) .50
Negative mood swings
 Mean (SD) 0.3 (2.2) 0.9 (2.4) < .01
Vision changes
 Mean (SD) 0.7 (1.8) 0.5 (1.3) .96

Change from baseline, Positive numbers indicate improvement.

a

Kruskal Wallis test.